期刊
MABS
卷 1, 期 4, 页码 382-384出版社
LANDES BIOSCIENCE
DOI: 10.4161/mabs.1.4.8860
关键词
patent; therapeutic; monoclonal antibodies; KSR; life cycle management
Patents provide one of the few protections companies can avail themselves of to help protect their therapeutic monoclonal antibody products. just as the therapeutic monoclonal antibody field is constantly evolving, so too is the legal environment surrounding these inventions. In a series of articles, the general state of the law surrounding therapeutic antibodies will be explained, and important challenges to this technology area will be discussed. Much is at stake when companies market therapeutic monoclonal antibodies; therefore, a firm understanding of this important form of protection is critically important for anyone developing such products.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据